Brighton Collaboration

Last updated
The Brighton Collaboration
Formation2000 (2000)
Type NPO
PurposeSafest, effective vaccines based on rigorous science
To enhance the science of vaccine research by providing standardized, validated, and objective methods for continuous monitoring of safety profiles and by assessing benefit-risk ratios. These methods are, in turn, recognized and recommended for use by international regulatory and public health agencies. [1]
Headquarters Basel, Switzerland
Region served
Worldwide
Official language
English
LeaderJan Bonhoeffer, president
Parent organization
 Task Force for Global Health
Affiliations Coalition for Epidemic Preparedness Innovations
Website brightoncollaboration.us

The Brighton Collaboration (BC) is a non-profit global vaccine safety research network based in Basel, Switzerland. It is named after the city in England where the idea was first formulated. [2]

Contents

History

The Brighton Collaboration was launched in 2000, although the idea of the collaboration started one year earlier, following a presentation by Bob Chen at an international scientific vaccine conference in Brighton. In his talk, he stressed the need to improve vaccine safety monitoring by developing internationally accepted standards. [3]

Organization

The Brighton Collaboration is a program of the Task Force for Global Health, a 501(c)(3) non-profit organization. It is primarily funded by the Coalition for Epidemic Preparedness Innovations (CEPI), and has received funding from a variety of scientific and public health organizations since its inception. [4]

Non-funding partners of the Collaboration include the Council for International Organizations of Medical Sciences, European Medicines Agency, Food and Drug Administration and the World Health Organization. [4]

References

  1. ↑ "EVI and Brighton Collaboration Foundation (BCF) sign Memorandum of Understanding (MoU)". Archived from the original on 2011-10-31. Retrieved 2012-07-17.
  2. ↑ Kohl, Katrin S.; Bonhoeffer, Jan; Braun, M. Miles; Chen, Robert T.; Duclos, Philippe; Heijbel, Harald; Heininger, Ulrich; Loupi, Elisabeth; Marcy, S. Michael (February 2005), Henriksen, Kerm; Battles, James B.; Marks, Eric S.; Lewin, David I. (eds.), "The Brighton Collaboration: Creating a Global Standard for Case Definitions (and Guidelines) for Adverse Events Following Immunization", Advances in Patient Safety: From Research to Implementation (Volume 2: Concepts and Methodology), Advances in Patient Safety, Rockville (MD): Agency for Healthcare Research and Quality (US), PMID   21249832, archived from the original on 2022-12-12, retrieved 2023-07-04
  3. ↑ Chen RT (1999). "Vaccine risks: real, perceived and unknown". Vaccine. 17 (Suppl 3): S41-6. doi:10.1016/s0264-410x(99)00292-3. PMID   10559533.
  4. 1 2 "Our Partners". Brighton Collaboration. Archived from the original on 2023-07-04. Retrieved 2023-07-04.


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.